Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE.TO)
announced today that it has entered into an agreement with Revera
Inc. (“Revera”) and certain of its affiliates to acquire nine Class
C long-term care (“LTC”) homes (the “Acquired Homes”) located in
Ontario and Manitoba and one parcel of vacant land located in
Ontario (the “Transaction”).
Closing of the Transaction is subject to
customary closing conditions, including receipt of regulatory
approvals from the Ontario Ministry of Long-Term Care, Ontario
Retirement Home Regulatory Authority, and Manitoba Health and
Winnipeg Regional Health Authority, and is not conditional on
financing or due diligence. The Transaction is anticipated to close
in mid-2025.
The aggregate cash consideration for the
Transaction is approximately $60.3 million, subject to customary
and other adjustments. The purchase price is expected to be funded
from cash on hand and existing senior secured credit
facilities.
Relatedly, Extendicare has been advised by
Revera that Revera has entered into a sale agreement with a third
party pursuant to which that third party will acquire 21 of
Revera’s Class C LTC homes located in Ontario that are currently
managed by Extendicare (the “Third-Party Sale”), subject to
regulatory approval. Upon closing of the two transactions,
Extendicare’s existing management agreements with Revera in respect
of the 30 homes, as well as related redevelopment arrangement
agreements, will terminate in accordance with their terms.
“This transaction adds approximately 1,100 beds
to our redevelopment pipeline, giving us control of the
redevelopment process for these homes,” said Dr. Michael Guerriere,
President and CEO of Extendicare. “Although we have generally
avoided purchasing Class C homes, this was a unique opportunity as
net operating income from the acquired homes more than offsets the
reduction in management fees, and the opportunity to sell seven
operational retirement homes once LTC redevelopment is complete
makes it likely we will recover most of the purchase price.”
Transaction Overview
The Acquired Homes encompass 1,396 beds in nine
homes, seven of which consist of a mix of 361 funded LTC beds and
574 private pay retirement beds. The LTC beds in these seven homes
are all C beds which we intend to redevelop and replace with six
new LTC homes comprising a proposed 361 replacement beds and 727
new beds. Also included in the 1,396 beds is the 250 bed Class C
Carlingview Manor home in Ottawa, which is in the process of being
redeveloped into a new LTC home that is owned by our joint venture
with Axium. We are committed to ensuring that the residents, their
families and staff at these homes are unaffected by this change in
ownership as Extendicare will continue to operate the homes in the
same manner as it currently does under current management
agreements. There are not expected to be any job losses as a result
of the Transaction.
The homes to be acquired in the Transaction are
set out in the table below.
Name |
Address |
LTC Beds(1) |
Retirement beds |
Blenheim Community Village |
Blenheim, ON |
57 |
30 |
Brierwood Gardens |
Brantford, ON |
67 |
71 |
Riverbend Place |
Cambridge, ON |
39 |
92 |
Summit Place |
Owen Sound, ON |
99 |
77 |
Telfer Place |
Paris, ON |
35 |
180 |
Village on the Ridge |
Ridgetown, ON |
30 |
65 |
Trillium Court |
Kincardine, ON |
34 |
59 |
Carlingview Manor(2) |
Ottawa, ON |
250 |
- |
Poseidon |
Winnipeg, MB |
211 |
- |
Total Beds |
|
822 |
574 |
(1) LTC Beds excludes 133 third
and fourth ward-style beds that have been taken out of service per
regulatory requirements that are eligible to be reinstated upon
redevelopment.(2) Carlingview Manor is in the
process of being redeveloped into a new 320-bed LTC home that is
owned by the Axium JV.
In accordance with the management agreements to be terminated on
completion of the Third-Party Sale, Revera is required to repay
Extendicare a portion of the consideration paid to Revera in
respect of the management agreements. Assuming completion of the
Third-Party Sale at the end of the second quarter of 2025,
Extendicare expects the repayment to be approximately $1.5
million.
The Transaction would add approximately $124.0
million and $13.0 million in annualized revenue and net operating
income(1) (“NOI”), respectively, to the Company’s LTC segment,
based on the actual revenue and NOI generated from the Acquired
Homes, adjusted for one-time items, for the nine-month period ended
September 30, 2024. Also, the loss of management fees as a result
of the Transaction and the Third-Party Sale would reduce the
Company’s managed services segment annualized revenue and NOI by
approximately $14.7 million and $6.2 million, respectively, based
on actual revenue and NOI, adjusted for one-time impacts, for the
nine months ended September 30, 2024. On a combined basis, the
annualized net effect of the Transaction and Third-Party Sale,
would be an increase in the Company’s consolidated revenue and NOI
of approximately $109.3 million and $6.8 million, respectively.
On the same basis, the annualized impact on
adjusted funds from operations (“AFFO”)(1), assuming the
Transaction is funded from cash on hand, would add approximately
$1.4 million (or AFFO/basic share of $0.02)
On a combined pro forma basis, giving effect to
the Transaction and the Third-Party Sale, the Company’s LTC segment
would own and operate 61 LTC homes with capacity for 8,509
residents, inclusive of these 574 private pay retirement beds
across 7 mixed use homes, and our Extendicare Assist division
within the managed services segment would provide management
contract services to 40 LTC homes with capacity for 5,943
residents.
Advisors
Torys LLP is acting as legal advisor to
Extendicare in connection with the Transaction. Stormont Partners
is acting as financial advisor to Revera and Goodmans LLP is acting
as legal advisor to Revera in connection with the Transaction.
About Extendicare
Extendicare is a leading provider of care and
services for seniors across Canada, operating under the
Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing
Partner Network brands. We are committed to delivering quality care
to meet the needs of a growing seniors’ population, inspired by our
mission to provide people with the care they need, wherever they
call home. We operate a network of 122 long-term care homes (52
owned, 70 under management contracts), deliver approximately 10.7
million hours of home health care services annually, and provide
group purchasing services to third parties representing
approximately 143,500 beds across Canada. Extendicare proudly
employs approximately 22,000 qualified, highly trained and
dedicated team members who are passionate about providing
high-quality care and services to help people live better.
Non-GAAP Measures
Certain measures used in this press release,
such as net operating income and adjusted funds from operations,
are not measures recognized under GAAP and do not have standardized
meanings prescribed by GAAP. These measures may differ from similar
computations as reported by other issuers and, accordingly, may not
be comparable to similarly titled measures as reported by such
issuers. These measures are not intended to replace earnings (loss)
from continuing operations or net earnings (loss), or other
measures of financial performance and liquidity reported in
accordance with GAAP. Such items are presented in this document
because management believes that they are relevant measures of
Extendicare’s operating performance and the impact of the
Transaction and Third-Party Sale thereon.
Detailed descriptions of these measures can be
found in Extendicare’s Q3 2024 Management’s Discussion &
Analysis (“MD&A”) (refer to “Non-GAAP Measures”), which is
available on SEDAR+ at www.sedarplus.ca and on Extendicare’s
website at www.extendicare.com.
Forward-looking Statements
This press release contains forward-looking
statements concerning anticipated future events, results,
circumstances, economic performance or expectations with respect to
Extendicare and its subsidiaries, including, without limitation,
statements regarding the Transaction, the Third-Party Sale, their
impact on the Company, and the potential redevelopment and
subsequent sale of the Acquired Homes. Forward-looking statements
can often be identified by the expressions “anticipate”, “believe”,
“estimate”, “expect”, “intend”, “objective”, “plan”, “project”,
“will”, “may”, “should” or other similar expressions or the
negative thereof. These forward-looking statements reflect
Extendicare’s current expectations regarding future results,
performance or achievements and are based upon information
currently available to it and on assumptions that Extendicare
believes are reasonable. These statements are not guarantees of
future performance and involve known and unknown risks,
uncertainties and other factors that may cause actual results,
performance or achievements of Extendicare to differ materially
from those expressed or implied in the statements. For further
information on the risks, uncertainties and assumptions that could
cause Extendicare’s actual results to differ from current
expectations, refer to “Risks and Uncertainties” and “Forward
Looking-Statements” in Extendicare’s Q3 2024 MD&A and latest
Annual Information Form filed by Extendicare with the securities
regulatory authorities, available at www.sedarplus.ca and on
Extendicare’s website at www.extendicare.com. Given these risks and
uncertainties, readers are cautioned not to place undue reliance on
Extendicare’s forward-looking statements. Except as required by
applicable securities laws, Extendicare assumes no obligation to
update or revise any forward-looking statements, whether as a
result of new information, future events or otherwise.
For further information, please
contact:
Investor Inquiries:
David BaconSenior Vice President and Chief
Financial OfficerEmail: david.bacon@extendicare.comPhone: (905)
470-5587
Endnotes:
(1) See the “Non-GAAP Measures” section of this
press release and Extendicare’s Q3 2024 MD&A, which includes
the reconciliation of such non-GAAP measure to the most directly
comparable GAAP measure.
Extendicare (TSX:EXE)
Historical Stock Chart
From Nov 2024 to Dec 2024
Extendicare (TSX:EXE)
Historical Stock Chart
From Dec 2023 to Dec 2024